DE69830336D1 - Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenie - Google Patents
Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenieInfo
- Publication number
- DE69830336D1 DE69830336D1 DE69830336T DE69830336T DE69830336D1 DE 69830336 D1 DE69830336 D1 DE 69830336D1 DE 69830336 T DE69830336 T DE 69830336T DE 69830336 T DE69830336 T DE 69830336T DE 69830336 D1 DE69830336 D1 DE 69830336D1
- Authority
- DE
- Germany
- Prior art keywords
- clozapine
- schizophrenia
- fatty acid
- treatment
- covalent conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/542—Carboxylic acids, e.g. a fatty acid or an amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/978,541 US6197764B1 (en) | 1997-11-26 | 1997-11-26 | Clozapine compositions and uses thereof |
US978541 | 1997-11-26 | ||
PCT/US1998/024412 WO1999026661A1 (en) | 1997-11-26 | 1998-11-16 | A covalent conjugate of clozapine with a fatty acid and its use for treating schizophrenia |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69830336D1 true DE69830336D1 (de) | 2005-06-30 |
DE69830336T2 DE69830336T2 (de) | 2006-01-26 |
Family
ID=25526196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69830336T Expired - Fee Related DE69830336T2 (de) | 1997-11-26 | 1998-11-16 | Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenie |
Country Status (9)
Country | Link |
---|---|
US (1) | US6197764B1 (de) |
EP (1) | EP1044023B1 (de) |
JP (1) | JP2001523732A (de) |
AT (1) | ATE296116T1 (de) |
AU (1) | AU746472B2 (de) |
CA (1) | CA2310850C (de) |
DE (1) | DE69830336T2 (de) |
ES (1) | ES2244098T3 (de) |
WO (1) | WO1999026661A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5994392A (en) | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
US6576636B2 (en) * | 1996-05-22 | 2003-06-10 | Protarga, Inc. | Method of treating a liver disorder with fatty acid-antiviral agent conjugates |
US5795909A (en) * | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US7235583B1 (en) * | 1999-03-09 | 2007-06-26 | Luitpold Pharmaceuticals, Inc., | Fatty acid-anticancer conjugates and uses thereof |
GB9930026D0 (en) * | 1999-12-21 | 2000-02-09 | Univ Sheffield | Novel compounds of unsaturated fatty acids |
US7666445B2 (en) * | 2000-10-20 | 2010-02-23 | The Trustees Of The University Of Pennsylvania | Polymer-based surgically implantable haloperidol delivery systems and methods for their production and use |
EP1423107B1 (de) * | 2001-03-23 | 2012-05-09 | Luitpold Pharmaceuticals, Inc. | Fettalkohol-arzneimittel-konjugate |
EP1427407A4 (de) * | 2001-03-23 | 2005-05-11 | Luitpold Pharm Inc | Fettamin-arzneimittel-konjugate |
ES2379544T3 (es) * | 2001-09-27 | 2012-04-27 | Ramot At Tel Aviv University Ltd. | Conjugado de perfenazina y GABA y usos del mismo |
AU2004201240B2 (en) * | 2001-09-27 | 2008-08-07 | Bar Ilan University | Conjugated Psychotropic Drugs and Uses Thereof |
US7544681B2 (en) * | 2001-09-27 | 2009-06-09 | Ramot At Tel Aviv University Ltd. | Conjugated psychotropic drugs and uses thereof |
NZ527142A (en) * | 2003-07-23 | 2006-03-31 | Douglas Pharmaceuticals Ltd | A stable suspension formulation |
EP2633853A1 (de) * | 2004-01-12 | 2013-09-04 | The Trustees of The University of Pennsylvania | Langzeitabgabe von Lieferungsformulierungen und Verwendungsverfahren dafür |
US8221778B2 (en) | 2005-01-12 | 2012-07-17 | The Trustees Of The University Of Pennsylvania | Drug-containing implants and methods of use thereof |
CA2551882A1 (en) * | 2004-01-19 | 2005-08-11 | Martek Biosciences Corporation | Reelin deficiency or dysfunction and methods related thereto |
US7427601B2 (en) * | 2004-06-24 | 2008-09-23 | Schwarz Pharma Ag | Method for treating tremor |
EP2626368B1 (de) | 2004-07-19 | 2016-12-21 | Biocon Limited | Insulinoligomerkonjugate, Formulierungen und Verwendungen davon |
ITMI20042232A1 (it) * | 2004-11-19 | 2005-02-19 | Unihart Corp | Composizione farmaceutica contenente clozapina |
US20060252749A1 (en) * | 2005-01-28 | 2006-11-09 | Srz Properties, Inc. | Lacosamide for add-on therapy of psychosis |
KR101255650B1 (ko) * | 2005-05-04 | 2013-04-16 | 프로노바 바이오파마 너지 에이에스 | 새로운 dha 유도체 및 약제로서의 용도 |
AU2006242914B2 (en) | 2005-05-04 | 2012-02-02 | Pronova Biopharma Norge As | New DHA derivatives and their use as medicaments |
EP2272537A3 (de) * | 2005-06-07 | 2014-10-22 | Ramot at Tel-Aviv University Ltd. | Salzen von Konjugaten bestehend aus psychotropischen Arzneimitteln und Prozessen zu ihrer Herstellung |
WO2006131923A2 (en) * | 2005-06-07 | 2006-12-14 | Ramot At Tel Aviv University Ltd. | Novel salts of conjugated psychotropic drugs and processes of preparing same |
US20080004260A1 (en) * | 2006-06-29 | 2008-01-03 | Transcept Pharmaceuticals, Inc. | Compositions of 5-HT3 antagonists and dopamine D2 antagonists for treatment of dopamine-associated chronic conditions |
EP2051735B1 (de) * | 2006-07-17 | 2012-08-29 | Ramot, at Tel Aviv University Ltd. | Konjugate mit einem psychotropische heilmittel oder einem gaba agonist und eine organische säure und ihre behandlung von schmerzen und andere erkrankungen des zns |
CA2667211A1 (en) | 2006-11-01 | 2008-05-08 | Pronova Biopharma Norge As | Alpha-substituted omega-3 lipids that are activators or modulators of the peroxisome proliferators-activated receptor (ppar) |
BRPI0818004B8 (pt) | 2007-10-16 | 2021-05-25 | Biocon Ltd | composição farmacêutica sólida administrável por via oral e o processo da mesma. |
US8207369B2 (en) * | 2008-02-11 | 2012-06-26 | Ramot At Tel-Aviv University Ltd. | Conjugates for treating neurodegenerative diseases and disorders |
US20100298397A1 (en) * | 2009-05-19 | 2010-11-25 | Singh Nikhilesh N | Method of treatment of obsessive compulsive disorder with ondansetron |
BR112012013639A2 (pt) * | 2009-12-09 | 2017-04-04 | Bar-Ilan Univ | "métodos pára melhorar funções congnitivas" |
CA2889457C (en) * | 2009-12-31 | 2016-06-28 | Kempharm, Inc. | Amino acid conjugates of quetiapine, process for making and using the same |
PL2544536T3 (pl) | 2010-03-11 | 2019-05-31 | Kempharm Inc | Koniugaty kwasów tłuszczowych z kwetiapiną, sposób ich wytwarzania i stosowania |
WO2012038963A1 (en) | 2010-09-22 | 2012-03-29 | Ramot At Tel-Aviv University Ltd. | An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same |
US8771972B2 (en) * | 2011-05-24 | 2014-07-08 | Saladax Biomedical Inc. | Clozapine immunoassay |
CN103408504A (zh) * | 2013-09-09 | 2013-11-27 | 海南中化联合制药工业股份有限公司 | 氯氮平晶体化合物、纳米速崩片剂及它们的制备方法 |
WO2018148529A1 (en) * | 2017-02-10 | 2018-08-16 | Florida A&M University | Identification of agents displaying functional activation of dopamine d2 and d4 receptors |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3539573A (en) | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
US4097597A (en) * | 1977-02-23 | 1978-06-27 | Abbott Laboratories | Dibenzo b,e! 1,4!diazepines |
US4351831A (en) | 1977-11-02 | 1982-09-28 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering isoxsurpine and choline |
US4346085A (en) | 1980-02-29 | 1982-08-24 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering amphetamine and choline |
US4636494A (en) | 1981-01-30 | 1987-01-13 | Massachusetts Institute Of Technology | Process and composition for treating disorders by administering amphetamine and choline |
US4558049A (en) | 1982-11-24 | 1985-12-10 | Farmitalia Carlo Erba S.P.A. | Antipsycotic benzoxazines |
US4684646A (en) | 1984-06-26 | 1987-08-04 | Merck & Co., Inc. | 2-acylaminomethyl-1,4-benzodiazepine derivatives as CCK-antagonists |
IL72684A (en) | 1984-08-14 | 1989-02-28 | Israel State | Pharmaceutical compositions for controlled transdermal delivery of cholinergic or anticholinergic basic drugs |
JPH075484B2 (ja) | 1985-03-06 | 1995-01-25 | 帝人株式会社 | 血液脳関門通過性医薬品組成物 |
US5223263A (en) | 1988-07-07 | 1993-06-29 | Vical, Inc. | Liponucleotide-containing liposomes |
US4692441A (en) | 1985-08-16 | 1987-09-08 | Merck & Co., Inc. | Chorine esters as absorption-enhancing agents for drug delivery through mucous membranes of the nasal, buccal, sublingual and vaginal cavities |
US4968672A (en) | 1987-01-02 | 1990-11-06 | The United States Of America As Represented By The Department Of Health And Human Services | Adenosine receptor prodrugs |
US5994392A (en) | 1988-02-26 | 1999-11-30 | Neuromedica, Inc. | Antipsychotic prodrugs comprising an antipsychotic agent coupled to an unsaturated fatty acid |
US5284876A (en) | 1988-02-26 | 1994-02-08 | Neuromedica, Inc. | Method of treating tardive dyskinesia using dopaminergic agents of prodrugs of therapeutic agents |
US4939174A (en) | 1988-02-26 | 1990-07-03 | Shashoua Victor E | Appetite suppression with dopamine-fatty acid conjugates |
US4933324A (en) | 1988-02-26 | 1990-06-12 | Shashoua Victor E | Fatty acid-neuroactive drug conjugate as a prodrug |
GB8813766D0 (en) | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
IE980216A1 (en) | 1989-04-17 | 2000-02-23 | Scotia Holdings Plc | Anti-virals |
US5411947A (en) | 1989-06-28 | 1995-05-02 | Vestar, Inc. | Method of converting a drug to an orally available form by covalently bonding a lipid to the drug |
JPH03236315A (ja) | 1989-12-05 | 1991-10-22 | Nippon Oil & Fats Co Ltd | 抗精神病薬 |
GB9001121D0 (en) | 1990-01-18 | 1990-03-21 | Efamol Holdings | Efa compositions and therapy |
US5827819A (en) * | 1990-11-01 | 1998-10-27 | Oregon Health Sciences University | Covalent polar lipid conjugates with neurologically active compounds for targeting |
US5214062A (en) | 1992-04-08 | 1993-05-25 | Clintec Nutrition Co. | Method and composition for treating immune disorders, inflammation and chronic infections |
US5308832A (en) | 1992-07-27 | 1994-05-03 | Abbott Laboratories | Nutritional product for persons having a neurological injury |
JPH0672868A (ja) | 1992-08-26 | 1994-03-15 | Maruha Corp | 抗精神病薬 |
FR2698269B1 (fr) | 1992-11-24 | 1995-01-06 | Inst Nat Sante Rech Med | Nouveaux médicaments à base d'acides gras insaturés, utilisables notamment comme antiagrégants plaquettaires et/ou comme transporteurs privilégiés vers le cerveau. |
GB9224809D0 (en) | 1992-11-26 | 1993-01-13 | Scotia Holdings Plc | Schizophrenia |
GB9300125D0 (en) | 1993-01-06 | 1993-03-03 | Scotia Holdings Plc | Compositions containing esters of unsaturated fatty acids |
GB9301629D0 (en) | 1993-01-27 | 1993-03-17 | Scotia Holdings Plc | Formulations containing unsaturated fatty acids |
JPH0782146A (ja) | 1993-07-23 | 1995-03-28 | Sagami Chem Res Center | 抗痴呆薬 |
IT1264987B1 (it) | 1993-12-14 | 1996-10-17 | Prospa Bv | Sali di un acido grasso poliinsaturo e formulazioni farmaceutiche che li contengono |
US5925669A (en) | 1994-03-22 | 1999-07-20 | Molecular/Structural Bio Technologies, Inc. | Carrier compositions for anti-neoplastic drugs |
US5604198A (en) | 1994-05-12 | 1997-02-18 | Poduslo; Joseph F. | Method to enhance permeability of the blood/brain blood/nerve barriers to therapeutic agents |
US5716614A (en) | 1994-08-05 | 1998-02-10 | Molecular/Structural Biotechnologies, Inc. | Method for delivering active agents to mammalian brains in a complex with eicosapentaenoic acid or docosahexaenoic acid-conjugated polycationic carrier |
EP0952841A4 (de) | 1994-08-05 | 2000-11-02 | Molecular Structural Biotechno | Biomolekulare komplexe für gerichteten transport von arzneimitteln in spezielle regionen |
JPH08151334A (ja) | 1994-11-25 | 1996-06-11 | Sagami Chem Res Center | リポソームおよびその製剤 |
JPH11502509A (ja) | 1995-01-16 | 1999-03-02 | コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼーション | 治療用化合物 − 脂肪酸抱合体 |
CN1488353A (zh) | 1995-03-06 | 2004-04-14 | Ӣ��Ŧ¡��ҩ����˾ | 用于治疗发生缺血患者的组合物 |
US5532374A (en) | 1995-06-06 | 1996-07-02 | Hitachi Chemical Company, Ltd. | Method of preparation of bis-quinolines |
JPH0930963A (ja) | 1995-07-21 | 1997-02-04 | Nisshin Oil Mills Ltd:The | 医療用油脂含有組成物 |
US5646180A (en) | 1995-12-05 | 1997-07-08 | Vertex Pharmaceuticals Incorporated | Treatment of the CNS effects of HIV |
US5795909A (en) | 1996-05-22 | 1998-08-18 | Neuromedica, Inc. | DHA-pharmaceutical agent conjugates of taxanes |
US5977174A (en) | 1997-11-26 | 1999-11-02 | Neuromedica, Inc. | Cholinergic compositions and uses thereof |
US5955459A (en) * | 1997-11-26 | 1999-09-21 | Neuromedica, Inc. | Fatty acid-antipsychotic compositions and uses thereof |
-
1997
- 1997-11-26 US US08/978,541 patent/US6197764B1/en not_active Expired - Fee Related
-
1998
- 1998-11-16 AT AT98957987T patent/ATE296116T1/de not_active IP Right Cessation
- 1998-11-16 EP EP98957987A patent/EP1044023B1/de not_active Expired - Lifetime
- 1998-11-16 AU AU14115/99A patent/AU746472B2/en not_active Ceased
- 1998-11-16 JP JP2000521862A patent/JP2001523732A/ja active Pending
- 1998-11-16 WO PCT/US1998/024412 patent/WO1999026661A1/en active IP Right Grant
- 1998-11-16 ES ES98957987T patent/ES2244098T3/es not_active Expired - Lifetime
- 1998-11-16 CA CA002310850A patent/CA2310850C/en not_active Expired - Fee Related
- 1998-11-16 DE DE69830336T patent/DE69830336T2/de not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2001523732A (ja) | 2001-11-27 |
EP1044023A1 (de) | 2000-10-18 |
ATE296116T1 (de) | 2005-06-15 |
US6197764B1 (en) | 2001-03-06 |
EP1044023B1 (de) | 2005-05-25 |
DE69830336T2 (de) | 2006-01-26 |
ES2244098T3 (es) | 2005-12-01 |
AU746472B2 (en) | 2002-05-02 |
CA2310850A1 (en) | 1999-06-03 |
CA2310850C (en) | 2009-09-29 |
WO1999026661A1 (en) | 1999-06-03 |
AU1411599A (en) | 1999-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69830336D1 (de) | Ein kovalentes konjugat von clozapine und einer fettsäure und dessen verwendung zur behandlung von schizophrenie | |
ATE273025T1 (de) | Dha-pharmazeutisches produkt konjugate | |
DE60023870D1 (de) | Verfahren zur herstellung von 3-aryloxy-3-arylpropylamine und deren zwischenprodukte | |
DE69836752D1 (de) | Prostaglandinagoniste und deren verwendung zur behandlung von knochenerkrankungen | |
ATE296634T1 (de) | (s,s)-reboxetin zur behandlung von fibromyalgie und anderen somatoformen störungen | |
DE60023128D1 (de) | Pyrazolecarboxamide zur behandlung von fettleibigkeit und anderen erkrankungen | |
DE69806579D1 (de) | Anlage zur behandlung von nahrungsmitteln | |
DE60027913D1 (de) | 5-beta-sapogenin und pseudosapogeninderivate und ihre verwendung zur behandlung von demenz | |
ATE438630T1 (de) | 5-sulfanyl-4h-1,2,4-triazolderivate und deren verwendung zur behandlung von somatostatine vermittelten krankheiten | |
ATA76995A (de) | Stabiles präparat zur behandlung von blutgerinnungsstörungen | |
DE10082139T1 (de) | Zusammensetzung zur Behandlung von Reibungspaaren | |
DE60034871D1 (de) | Verfahren und zusammensetzungen zur prevention oder behandlung von krebs und von krebs assoziertem knochenverlust | |
DE69528710D1 (de) | 2-substituierte 1,2,5-thiadiazolidin-3-on-1,1-dioxiden, zusammensetzung und deren verwendung | |
DE69405919D1 (de) | Zusammensetzungen zur Behandlung von Keratinfasern | |
DE69429806T2 (de) | Pharmazeutische zusammensetzungen zur prävention und behandlung von krebserkrankungen und verfahren für ihre herstellung | |
DE60027429D1 (de) | Dihydrobenzodiazepinen und deren verwendung zur behandlung von dyslipidämien | |
DE69331479T2 (de) | Polyethylenglycol-Hirudin-Konjugate, deren Verfahren zur Herstellung und Verwendung für die Heilung von Thrombosen | |
DE69931487D1 (de) | Verwendung von apomorphin zur behandlung der vorzeitigen ejakulation | |
DE69822297D1 (de) | Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten | |
DE60001255T2 (de) | Zusammensetzung zur Behandlung von Polyesterfaser | |
TR200200278T2 (tr) | Kalsilitik bileşimler | |
DE69729735D1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
DE69913380D1 (de) | Zusammensetzung zur behandlung von periodontalen erkrankungen | |
ATE215525T1 (de) | Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung | |
ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |